GENMAB A/S - SPONSORED ADS (GMAB)

Historical Holders from Q1 2014 to Q4 2025

Symbol: GMAB on Nasdaq
Type / Class: Equity / SPONSORED ADS
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 61,572,089
Holdings value: $1,888,414,988
% of all portfolios: 0%
Number of holders: 243
Number of buys: 155
Number of sells: 88
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025 GENMAB A/S - SPONSORED ADS (GMAB) has 243 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 61,572,089 shares of the company stock as of 30 Sep 2025.

Institutional Holders of GENMAB A/S - SPONSORED ADS (GMAB) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	34,586	$1,064,854	+$86,217			$30.80	5
2025 Q3	61,572,089	$1,888,414,988	-$41,493,952	$312,834	$1,803,396	$30.67	243
2025 Q2	63,662,903	$1,315,290,222	-$19,336,984	$1,136,300	$671,450	$20.66	213
2025 Q1	64,849,583	$1,269,852,791	+$73,035,748	$7,792,840	$14,273,820	$19.58	217
2024 Q4	60,769,608	$1,268,138,468	+$161,166,233	$793,060	$3,316,243	$20.87	227
2024 Q3	52,167,041	$1,271,406,555	+$95,151,333	$621,690	$248,676	$24.38	219
2024 Q2	48,732,629	$1,226,846,131	+$16,515,174	$693,588	$170,884	$25.13	217
2024 Q1	47,865,207	$1,431,460,622	+$35,418,945	$1,157,517	$936,183	$29.91	223
2023 Q4	46,634,034	$1,478,140,959	-$36,372,955	$89,152	$936,096	$31.84	223
2023 Q3	47,456,065	$1,674,482,707	+$198,240,982	$1,985,701	$1,294,409	$35.27	232
2023 Q2	41,697,685	$1,582,923,378	-$44,265,049	$623,364	$547,344	$38.01	211
2023 Q1	42,440,813	$1,601,471,519	-$113,536,012	$4,127,168	$5,690,432	$37.76	212
2022 Q4	45,784,677	$1,940,975,830	+$67,141,764	$1,216,306	$1,089,166	$42.38	232
2022 Q3	44,421,336	$1,426,539,749	+$286,435,137		$6,555,000	$32.13	185
2022 Q2	35,500,267	$1,150,049,837	-$98,089,579		$4,406,000	$32.49	171
2022 Q1	38,997,998	$1,412,600,597	-$26,246,934	$0	$847,000	$36.18	192
2021 Q4	39,758,410	$1,575,069,687	-$119,701,927	$265,000	$261,000	$39.56	201
2021 Q3	42,689,111	$1,858,636,856	-$95,300,984	$931,000	$6,776,000	$43.70	204
2021 Q2	46,169,307	$1,888,846,647	+$355,328,756	$3,038,000	$4,846,000	$40.83	206
2021 Q1	41,808,726	$1,368,072,549	-$31,901,016	$7,006,000	$4,091,000	$32.83	202
2020 Q4	42,235,568	$1,718,070,352	+$62,337,397	$3,444,000	$3,574,000	$40.66	221
2020 Q3	40,922,682	$1,501,467,997	+$114,003,080	$1,977,000	$5,479,000	$36.61	194
2020 Q2	37,732,614	$1,275,132,966	+$323,990,293	$604,000	$3,012,000	$33.89	165
2020 Q1	28,291,640	$599,731,369	+$101,071,476	$256,000		$21.19	130
2019 Q4	23,477,852	$524,334,188	-$30,208,611			$22.33	122
2019 Q3	25,179,716	$510,167,549	+$484,997,137			$20.26	94
2019 Q2	1,074,192	$19,832,921	+$889,082			$18.35	6
2019 Q1	1,026,230	$17,894,911	+$11,917,043			$17.44	7
2018 Q4	342,843	$5,645,000	+$456,183			$16.00	6
2018 Q3	315,649	$5,044,000	-$1,854,111			$15.75	5
2018 Q2	437,666	$6,707,000	+$5,406,851			$15.32	5
2018 Q1	84,832	$9,189,000	+$4,311,787			$107.05	5
2017 Q4	45,079	$3,736,000	+$114,060			$82.85	4
2017 Q3	43,176	$4,773,000	+$765,071			$110.57	5
2017 Q2	36,255	$3,874,000	+$1,291,383			$106.88	4
2017 Q1	24,155	$2,338,000	+$562,901			$96.80	3
2016 Q4	18,337	$1,520,000	+$1,248,402			$82.89	2
2016 Q3	3,278	$280,000	-$47,322			$85.42	1
2016 Q2	3,832	$350,000	+$350,000			$91.34	1
2014 Q4	0	$0	-$9,000				0
2014 Q3	445	$9,000	+$6,472			$20.22	1
2014 Q2	125	$3,000	+$216			$24.00	1
2014 Q1	116	$2,000	+$2,000			$17.24	1